Letters in Drug Design and Discovery

SJR Rank #17,178H-index: 41SJR: 0.301Best quartile: Q3APC: US$2,300
Journal website: aims, scope and author guidelines
Publisher

KeAi Communications Co.

Country

China

Type

journal

SJR by Edition

2022202500.080.160.240.32

Subject Categories

  • Drug DiscoveryQ3
  • Pharmaceutical ScienceQ3
  • Molecular MedicineQ4

Areas: Biochemistry, Genetics and Molecular Biology · Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Synthesis and biological activityComputational Drug Discovery MethodsSynthesis and Characterization of Heterocyclic CompoundsClick Chemistry and ApplicationsChemical Synthesis and AnalysisSynthesis and Biological EvaluationSynthesis and Reactions of Organic CompoundsCancer therapeutics and mechanismsPhenothiazines and Benzothiazines Synthesis and ActivitiesCholinesterase and Neurodegenerative Diseases

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs0200400600800

Documents per Year

2022202504590135180

Detailed Information

ISSN

1875-628X, 1570-1808

SJR Best Quartile

Q3

Region

Asiatic Region

Citations per Document (2 years)

1.71

References per Document

55.87

Coverage

2005-2026

Scope

No scope description available yet.

Metrics from SCImago Journal Rank 2025. View on SCImago